Amphastar Pharmaceuticals Inc expected to post earnings of 37  cents a share - Earnings Preview

Amphastar Pharmaceuticals,

08/03/2022 22:20

* Amphastar Pharmaceuticals Inc  AMPH.OQ   AMPH.O  is
expected
to show a rise in quarterly revenue when it reports  results on
March 10. 
    * The Rancho Cucamonga California-based  company is expected
to
report  a 16.2% increase in revenue to $111.444 million from
$95.92 million a year ago, according to the mean estimate from 5
analysts, based on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Amphastar
Pharmaceuticals
Inc is for earnings of 37 cents per share. For the same quarter
last year, the company reported earnings of 16 cents per share.
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," 3
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Amphastar
Pharmaceuticals Inc is $28.5​, below​ its last closing price
of $30.74. ​​​
    * Previous quarterly performance (using preferred earnings
measure
in US dollars). ​

 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Sep. 30 2021  0.25        0.24       0.46      Beat    89
 Jun. 30 2021  0.22        0.21       0.21      Met     0.8
 Mar. 31 2021  0.18        0.18       0.27      Beat    46.5​
 Dec. 31 2020              0.14       0.16      Beat    16.7
 ​​Sep.        0.15        0.14       0.15      Beat    6.8
 30 2020                                                
 Jun. 30 2020  0.14        0.14       0.16      Beat    17.9​
 Mar. 31 2020  0.08        0.09       0.17      Beat    97.7
 Dec. 31 2019  -0.01       0.07       0.07      Met     -5.6
 This summary was machine generated March 8 at 22:20 GMT.  All
figures in US dollars  unless otherwise stated